These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

856 related articles for article (PubMed ID: 15705911)

  • 1. Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity.
    Hirano F; Kaneko K; Tamura H; Dong H; Wang S; Ichikawa M; Rietz C; Flies DB; Lau JS; Zhu G; Tamada K; Chen L
    Cancer Res; 2005 Feb; 65(3):1089-96. PubMed ID: 15705911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PD-1/B7-H1 interaction contribute to the spontaneous acceptance of mouse liver allograft.
    Morita M; Fujino M; Jiang G; Kitazawa Y; Xie L; Azuma M; Yagita H; Nagao S; Sugioka A; Kurosawa Y; Takahara S; Fung J; Qian S; Lu L; Li XK
    Am J Transplant; 2010 Jan; 10(1):40-6. PubMed ID: 19889124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of B7-H1 or B7-DC induces an anti-tumor effect in a mouse pancreatic cancer model.
    Okudaira K; Hokari R; Tsuzuki Y; Okada Y; Komoto S; Watanabe C; Kurihara C; Kawaguchi A; Nagao S; Azuma M; Yagita H; Miura S
    Int J Oncol; 2009 Oct; 35(4):741-9. PubMed ID: 19724910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B7-H1 expression on old CD8+ T cells negatively regulates the activation of immune responses in aged animals.
    Mirza N; Duque MA; Dominguez AL; Schrum AG; Dong H; Lustgarten J
    J Immunol; 2010 May; 184(10):5466-5474. PubMed ID: 20375308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemia.
    Zhou Q; Munger ME; Highfill SL; Tolar J; Weigel BJ; Riddle M; Sharpe AH; Vallera DA; Azuma M; Levine BL; June CH; Murphy WJ; Munn DH; Blazar BR
    Blood; 2010 Oct; 116(14):2484-93. PubMed ID: 20570856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of endogenous B7-H1 suppresses antibacterial protection after primary Listeria monocytogenes infection.
    Seo SK; Jeong HY; Park SG; Lee SW; Choi IW; Chen L; Choi I
    Immunology; 2008 Jan; 123(1):90-9. PubMed ID: 17971153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells.
    Azuma T; Yao S; Zhu G; Flies AS; Flies SJ; Chen L
    Blood; 2008 Apr; 111(7):3635-43. PubMed ID: 18223165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of programmed death 1 ligands by murine T cells and APC.
    Yamazaki T; Akiba H; Iwai H; Matsuda H; Aoki M; Tanno Y; Shin T; Tsuchiya H; Pardoll DM; Okumura K; Azuma M; Yagita H
    J Immunol; 2002 Nov; 169(10):5538-45. PubMed ID: 12421930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of PD-1/B7-H1 interaction restores effector CD8+ T cell responses in a hepatitis C virus core murine model.
    Lukens JR; Cruise MW; Lassen MG; Hahn YS
    J Immunol; 2008 Apr; 180(7):4875-84. PubMed ID: 18354211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PD-1/PD-L blockade prevents anergy induction and enhances the anti-tumor activities of glycolipid-activated invariant NKT cells.
    Parekh VV; Lalani S; Kim S; Halder R; Azuma M; Yagita H; Kumar V; Wu L; Kaer LV
    J Immunol; 2009 Mar; 182(5):2816-26. PubMed ID: 19234176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NK cells that are activated by CXCL10 can kill dormant tumor cells that resist CTL-mediated lysis and can express B7-H1 that stimulates T cells.
    Saudemont A; Jouy N; Hetuin D; Quesnel B
    Blood; 2005 Mar; 105(6):2428-35. PubMed ID: 15536145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B7-H1-induced apoptosis as a mechanism of immune privilege of corneal allografts.
    Hori J; Wang M; Miyashita M; Tanemoto K; Takahashi H; Takemori T; Okumura K; Yagita H; Azuma M
    J Immunol; 2006 Nov; 177(9):5928-35. PubMed ID: 17056517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of B7-H1 suppresses the development of chronic intestinal inflammation.
    Kanai T; Totsuka T; Uraushihara K; Makita S; Nakamura T; Koganei K; Fukushima T; Akiba H; Yagita H; Okumura K; Machida U; Iwai H; Azuma M; Chen L; Watanabe M
    J Immunol; 2003 Oct; 171(8):4156-63. PubMed ID: 14530338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human rhinoviruses inhibit the accessory function of dendritic cells by inducing sialoadhesin and B7-H1 expression.
    Kirchberger S; Majdic O; Steinberger P; Blüml S; Pfistershammer K; Zlabinger G; Deszcz L; Kuechler E; Knapp W; Stöckl J
    J Immunol; 2005 Jul; 175(2):1145-52. PubMed ID: 16002716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory and conventional CD4+ T cells show differential effects correlating with PD-1 and B7-H1 expression after immunotherapy.
    Alderson KL; Zhou Q; Berner V; Wilkins DE; Weiss JM; Blazar BR; Welniak LA; Wiltrout RH; Redelman D; Murphy WJ
    J Immunol; 2008 Mar; 180(5):2981-8. PubMed ID: 18292520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of B7-H1 on macrophages suppresses CD4+ T cell proliferation by augmenting IFN-gamma-induced nitric oxide production.
    Yamazaki T; Akiba H; Koyanagi A; Azuma M; Yagita H; Okumura K
    J Immunol; 2005 Aug; 175(3):1586-92. PubMed ID: 16034097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Target-dependent B7-H1 regulation contributes to clearance of central nervous system infection and dampens morbidity.
    Phares TW; Ramakrishna C; Parra GI; Epstein A; Chen L; Atkinson R; Stohlman SA; Bergmann CC
    J Immunol; 2009 May; 182(9):5430-8. PubMed ID: 19380790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
    Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
    J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutting edge: Programmed death-1/programmed death ligand 1 interaction regulates the induction and maintenance of invariant NKT cell anergy.
    Chang WS; Kim JY; Kim YJ; Kim YS; Lee JM; Azuma M; Yagita H; Kang CY
    J Immunol; 2008 Nov; 181(10):6707-10. PubMed ID: 18981087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of programmed death ligand 1 enhances the therapeutic efficacy of combination immunotherapy against melanoma.
    Pilon-Thomas S; Mackay A; Vohra N; Mulé JJ
    J Immunol; 2010 Apr; 184(7):3442-9. PubMed ID: 20194714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.